Steroid Taper

Exponential taper calculator with PJP prophylaxis safety checks

Taper Parameters

Patient Name

Start Date

Starting Dose (mg)

Target Dose (mg)

Duration of Taper (weeks)

Days at each dose level

Available Tablet Sizes (mg)

25mg

5mg

1mg

Tablets can be halved

CTCAE v5.0

Common Terminology Criteria for Adverse Events Reference

Search Adverse Event

Filter by System Organ Class

Page 1 of 1

RECIST 1.1 Calculator

Response Evaluation Criteria in Solid Tumours

Measurements

Target Lesions

Site (Opt)	Baseline (mm)	Nadir (mm)	Current (mm)
SUM	0.0	0.0	0.0

Leave Nadir blank if this is the first evaluation (defaults to Baseline).

Non-Target Lesion Status

New Lesions Present

Overall Response

Evaluation

N/A

Target Lesion Response	-
% Change from Baseline	-
% Change from Nadir	-

PCWG3 & 4 Calculator

Prostate Cancer Clinical Trials Working Group Criteria

Clinical Assessments

Imaging Modality

Radiographic Evaluation

New lesions on 1st post-tx scan (Flare Window)

New lesions on subsequent scans

Soft Tissue (RECIST 1.1)

Biochemical (PSA)

Baseline PSA

Nadir PSA

Current PSA

Independent Assessments

PCWG emphasizes reporting efficacy separately for different disease manifestations.

Radiographic (Bone/PET)

Evaluation pending

N/A

Soft Tissue

RECIST 1.1 Criteria

N/A

Biochemical (PSA)

Evaluation pending

N/A

Taper Parameters

Taper Schedule

Measurements

Overall Response

Clinical Assessments

Radiographic Evaluation

Soft Tissue (RECIST 1.1)

Biochemical (PSA)

Independent Assessments